Assignee
CORMEDIX INC
US·7 granted patents·23 pending applications·1 citations·filing 2007–2025
Top patents by PatentIndex Score
30 records- 0181US2025374925A1Antimicrobial compositions, including antimicrobial hydrogels, effective against mature biofilmsCORMEDIX INC·Filed 2025·Application pending·0 cites
- 0279US2025144111A1Taurolidine treatment for myc-expressing tumors in mammalian bodiesCORMEDIX INC·Filed 2024·Application pending·0 cites
- 0375US12053478B2Taurultam, taurinamide and methylene glycol treatment for MYC—expressing tumors in mammalian bodiesCORMEDIX INC·Filed 2021·Granted Aug 6, 2024·0 cites·10 claims
- 0474US2025099480A1Methods and pharmaceutical compositions for treating candida auris in bloodCORMEDIX INC·Filed 2024·Application pending·0 cites
- 0569US12302902B2Antimicrobial compositions, including antimicrobial hydrogels, effective against mature biofilmsCORMEDIX INC·Filed 2018·Granted May 20, 2025·0 cites·5 claims
- 0669US11541061B2Neuroblastoma treatment with taurolidine hydrolysis productsCORMEDIX INC·Filed 2019·Granted Jan 3, 2023·0 cites·3 claims
- 0769US2023390300A1Neuroblastoma treatment with taurolidine hydrolysis productsCORMEDIX INC·Filed 2022·Application pending·0 cites
- 0868US2019381060A1Taurolidine treatment for myc-expressing tumors in mammalian bodiesCORMEDIX INC·Filed 2019·Application pending·0 cites
- 0967US12016865B2Methods and pharmaceutical compositions for treating candida auris in bloodCORMEDIX INC·Filed 2018·Granted Jun 25, 2024·0 cites·14 claims
- 1067US2022362258A1Therapeutic nanoparticles for the treatment of neuroblastoma and other cancersCORMEDIX INC·Filed 2022·Application pending·0 cites
- 1166US2022347184A1Skin-penetrating formulation of taurolidineCORMEDIX INC·Filed 2022·Application pending·0 cites
- 1265US2022323450A1Methods and compositions for treating neuroblastoma in a juvenile mammalian bodyCORMEDIX INC·Filed 2021·Application pending·0 cites
- 1363US10517984B2Antimicrobial wound closure materials, including antimicrobial sutures, and method for closing a wound using the sameCORMEDIX INC·Filed 2016·Granted Dec 31, 2019·1 cites·31 claims
- 1462US2019381058A1Methods and compositions for treating neuroblastoma in a juvenile mammalian bodyCORMEDIX INC·Filed 2019·Application pending·0 cites
- 1558US2021093641A1Skin-penetrating formulation of taurolidineCORMEDIX INC·Filed 2020·Application pending·0 cites
- 1656US2018117058A1Skin-penetrating formulation of taurolidineCORMEDIX INC·Filed 2017·Application pending·0 cites
- 1755US11738120B1Synthesis of taurolidine, purity profiles and polymorphsCORMEDIX INC·Filed 2022·Granted Aug 29, 2023·0 cites·24 claims
- 1854US2020390931A1Antimicrobial wound closure materials, including antimicrobial sutures, and method for closing a wound using the sameCORMEDIX INC·Filed 2019·Application pending·0 cites
- 1953US2025249153A1Improved Synthesis of Taurolidine, Purity Profiles and PolymorphsCORMEDIX INC·Filed 2023·Application pending·0 cites
- 2046US2019192552A1Pharmaceutical compositions and methods for treating keloids, hypertrophic scars and wounds, and for providing improved skin careCORMEDIX INC·Filed 2018·Application pending·0 cites
- 2146US2018207103A1Use of an injectable antimicrobial composition for the prevention and/or treatment of osteoarthritisCORMEDIX INC·Filed 2018·Application pending·0 cites
- 2246US2018185378A1Antimicrobial delivery system for the prevention and treatment of infections in the colonCORMEDIX INC·Filed 2018·Application pending·0 cites
- 2345US2017196875A1Therapeutic nanoparticles for the treatment of neuroblastoma and other cancersCORMEDIX INC·Filed 2017·Application pending·0 cites
- 2444US2020030337A1Delivery of active agents using nanofiber websCORMEDIX INC·Filed 2019·Application pending·0 cites
- 2544US2021085686A1Delivery of active agents using nanofiber websCORMEDIX INC·Filed 2020·Application pending·0 cites
- 2644US2017100407A1Skin-penetrating formulation of taurolidineCORMEDIX INC·Filed 2016·Application pending·0 cites
- 2742US10478640B2Field sterilizer and vascular connector kitCORMEDIX INC·Filed 2017·Granted Nov 19, 2019·0 cites·3 claims
- 2840US2008138440A1Methods of diagnosing and alleviating gadolinium toxicityCORMEDIX INC·Filed 2007·Application pending·0 cites
- 2936US2017056333A1Delivery of active agents using nanofiber websCORMEDIX INC·Filed 2016·Application pending·0 cites
- 3036US2017056561A1Compositions for the treatment of jointsCORMEDIX INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CORMEDIX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →